HomeNEUP • NASDAQ
add
Neuphoria Therapeutics Inc
Previous close
$17.50
Day range
$16.51 - $18.39
Year range
$2.91 - $21.40
Market cap
39.54M USD
Avg Volume
87.21K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | -13.27K | — |
Operating expense | 11.08M | -6.12% |
Net income | -8.88M | -230.61% |
Net profit margin | 66.96K | — |
Earnings per share | -5.55 | — |
EBITDA | -5.67M | -6.75% |
Effective tax rate | 2.91% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 14.21M | 12.71% |
Total assets | 28.59M | 3.40% |
Total liabilities | 9.59M | -5.63% |
Total equity | 19.00M | — |
Shares outstanding | 2.36M | — |
Price to book | 1.82 | — |
Return on assets | -49.21% | — |
Return on capital | -64.39% | — |
Cash Flow
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -8.88M | -230.61% |
Cash from operations | -3.59M | -19.07% |
Cash from investing | — | — |
Cash from financing | 704.68K | -90.11% |
Net change in cash | -2.83M | -167.67% |
Free cash flow | -1.50M | — |
About
Founded
1996
Headquarters
Website
Employees
8
